CLIN CHEM LAB MED:间接法检测地中海成人血清促甲状腺素(TSH)的参考区间及其与年龄和性别的关系

2019-11-17 MedSci MedSci原创

血清促甲状腺激素(TSH)浓度是诊断算法中的一线检测指标。估计TSH参考区间(RIs)目前仍有争议,因为亚临床疾病的高发病率使难以界定真正健康的受试者。本研究的目的是估计健康受试者的TSH RIs,并评估年龄和性别对TSH浓度的影响。

血清促甲状腺激素(TSH)浓度是诊断算法中的一线检测指标。估计TSH参考区间(RIs)目前仍有争议,因为亚临床疾病的高发病率使难以界定真正健康的受试者。本研究的目的是估计健康受试者的TSH RIs,并评估年龄和性别对TSH浓度的影响。

20127月至20184月期间,巴勒莫大学-医院检验医学部收集了大量的TSH数据。排除15岁以下的个体、重复TSH检测的受试者以及游离甲状腺素(fT4)、游离三碘甲状腺氨酸(fT3)或抗甲状腺过氧化物酶抗体异常的受试者后,用Arzideh间接法估计常见和性别特异性RIs。评价年龄和性别对TSH值的综合影响。

在被选择的个体(n = 22602)RIs分别为0.18-3.54 mIU/L(一般)0.19-3.23 mIU/L(男性)0.18-3.94 mIU/L(女性)。女性TSH中位数明显高于男性(1.461.39 mIU/L;p < 0.0001)。无论男性还是女性,TSH中值均随年龄下降;然而,尽管在60岁之前男性和女性都表现出相似的趋势,但之后女性的TSH持续高于男性。因此,统计分析显示性别与年龄之间存在显著的交互作用(p = 0.001),提示年龄对TSH的影响在性别间存在差异。研究表明,间接方法,并结合适当的数据过滤,可能会有益于定义TSH RIs

原始出处:

Bruna Lo SassoMatteo VidaliReference interval by the indirect approach of serum thyrotropin (TSH) in a Mediterranean adult population and the association with age and gender

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1407804, encodeId=9fd0140e804e1, content=<a href='/topic/show?id=e0731e891b9' target=_blank style='color:#2F92EE;'>#TSH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17891, encryptionId=e0731e891b9, topicName=TSH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546912, encodeId=c2f51546912d0, content=<a href='/topic/show?id=ed723e350e0' target=_blank style='color:#2F92EE;'>#参考区间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37350, encryptionId=ed723e350e0, topicName=参考区间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=910c13959987, createdName=12498dabm81暂无昵称, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575508, encodeId=7d0015e55089c, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610136, encodeId=e9ba161013626, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=)]
    2019-11-19 xinxin088
  2. [GetPortalCommentsPageByObjectIdResponse(id=1407804, encodeId=9fd0140e804e1, content=<a href='/topic/show?id=e0731e891b9' target=_blank style='color:#2F92EE;'>#TSH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17891, encryptionId=e0731e891b9, topicName=TSH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546912, encodeId=c2f51546912d0, content=<a href='/topic/show?id=ed723e350e0' target=_blank style='color:#2F92EE;'>#参考区间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37350, encryptionId=ed723e350e0, topicName=参考区间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=910c13959987, createdName=12498dabm81暂无昵称, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575508, encodeId=7d0015e55089c, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610136, encodeId=e9ba161013626, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1407804, encodeId=9fd0140e804e1, content=<a href='/topic/show?id=e0731e891b9' target=_blank style='color:#2F92EE;'>#TSH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17891, encryptionId=e0731e891b9, topicName=TSH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546912, encodeId=c2f51546912d0, content=<a href='/topic/show?id=ed723e350e0' target=_blank style='color:#2F92EE;'>#参考区间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37350, encryptionId=ed723e350e0, topicName=参考区间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=910c13959987, createdName=12498dabm81暂无昵称, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575508, encodeId=7d0015e55089c, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610136, encodeId=e9ba161013626, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=)]
    2019-11-19 wgx311
  4. [GetPortalCommentsPageByObjectIdResponse(id=1407804, encodeId=9fd0140e804e1, content=<a href='/topic/show?id=e0731e891b9' target=_blank style='color:#2F92EE;'>#TSH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17891, encryptionId=e0731e891b9, topicName=TSH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546912, encodeId=c2f51546912d0, content=<a href='/topic/show?id=ed723e350e0' target=_blank style='color:#2F92EE;'>#参考区间#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37350, encryptionId=ed723e350e0, topicName=参考区间)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=910c13959987, createdName=12498dabm81暂无昵称, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575508, encodeId=7d0015e55089c, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610136, encodeId=e9ba161013626, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Nov 19 12:25:00 CST 2019, time=2019-11-19, status=1, ipAttribution=)]

相关资讯

Stroke:缺血性卒中治疗的年龄和性别差异

由此可见,老年患者和所有年龄段的女性进入卒中单元接受治疗有所增加。尽管IVT使用方面没有性别差异,但进一步调查各年龄段缺血性卒中女性接受MT频率显著更高尤为重要。

Clin Endocrinol:肥胖对甲状腺癌风险的影响因年龄而异

目前,肥胖与分化型甲状腺癌(DTC)之间的关系仍存争议。有些研究显示,两者呈正相关;但也有研究显示两者之间并无显著关系。此外,既往有关肥胖与DTC关系的研究主要是在西方人群中进行,而亚洲人群的相关研究证据较少。近期在Clinical Endocrinology杂志上发表的一项最新研究为我们带来了中国人群中肥胖与DTC相关的新数据。其结果显示,与无甲状腺疾病的对照者相比,中国成年DTC患者更多伴有超

Nat Med: 年纪越大体重越难控制,新研究揭示背后原因

许多人都在努力控制自己的体重。然而,随着年龄的增长,减轻体重变得越来越困难,甚至身边经常有人抱怨,喝水发胖,连呼吸都会变胖。太难了,减肥真的太难了。那这到底是为什么?

J Neurosci:耳蜗传出神经分布在人类中是稀疏的并随着年龄减少

哺乳动物的耳蜗由2个胆碱能反馈系统支配,分别为内侧(M)和外侧(L)橄榄耳蜗(OC)途径,这些途径能够将脑干控制信号分别传输到外听毛细胞和听觉神经纤维。尽管在动物模型中关于这些传出神经纤维的耳蜗透射已经有大量的研究,而关于人类的比较数据仍旧缺乏,最近,有研究人员对来自于23名正常老化人类(14名男性,9名女性)的耳蜗感觉上皮进行了免疫染色,他们的年龄为0-86岁,并利用胆碱能标记对MOC和LOC透

JACC:年龄相关的心功能变化指标与BNP的相关性研究

年龄对心脏功能的影响尚未完全阐明,斑点追踪心超可以发现亚临床心功能不全。本研究的目的旨在评估健康的年龄对左室(LV)、右室(RV)和左房(LA)的影响,以及他们与血清B型钠尿肽(BNP)的相关性。本研究对481名体重健康的正常人(平均年龄60±12岁,男性占46%)进行了斑点追踪检测以评估左室整体纵向应变(LVGLS)、右室游离壁应变和左室相应变。BNP水平升高定义为男性BNP >37.82

Science:揭秘女性生育能力随年龄增长下降背后的机制

女性的生育能力呈现倒U形曲线,在进入青春期前和30岁之后生育能力较低,24岁至29岁则是女性的最佳生育年龄。到底是什么原因造成这种现象呢?《Science》杂志发表的一篇文章或能给出答案。